首页> 外文期刊>Current opinion in pulmonary medicine >The Pseudomonas aeruginosa genome How do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections?
【24h】

The Pseudomonas aeruginosa genome How do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections?

机译:铜绿假单胞菌基因组我们如何使用它来开发治疗囊性纤维化和假单胞菌感染患者的策略?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In the 2 years since the complete sequence of strain PAO1 was published, at least 200 papers have been published describing research that made use of the PAO1 genome sequence. Some of this research included genome-wide studies of gene expression or the effect of mutation on bacterial functions such as biofilm formation; this type of global analysis would not have been possible without the availability of the sequence. As a result of these and other, more traditional, research studies, there is a wealth of new knowledge about the physiology of this pathogen. This raises the possibility of new strategies for the treatment of patients with infection, either by novel antibiotics or by drugs targeting bacterial functions essential for survival and virulence in the human host.
机译:自菌株PAO1的完整序列发布以来的两年中,至少有200篇论文发表,描述了利用PAO1基因组序列的研究。一些研究包括基因表达的全基因组研究或突变对细菌功能(如生物膜形成)的影响;没有序列的可用性,这种类型的全局分析将是不可能的。这些研究以及其他更传统的研究的结果,是关于这种病原体的生理学的大量新知识。这增加了通过新型抗生素或靶向针对人类宿主生存和毒力必不可少的细菌功能的药物来治疗感染患者的新策略的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号